Single Dose Administration of Alpha-1 Anti-Trypsin for the Amelioration of Organ Injury in Patients Undergoing Cardiac Surgery

NCT02191839 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Post Cardiac Surgery Systemic Inflammatory Response

Interventions

DRUG: Alpha 1-Antitrypsin

Sponsor

Soroka University Medical Center